These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 33158544)
1. The impact of TLR7 agonist R848 treatment on mast cell phenotype and activity. Agier J; Brzezińska-Błaszczyk E; Witczak P; Kozłowska E; Żelechowska P Cell Immunol; 2021 Jan; 359():104241. PubMed ID: 33158544 [TBL] [Abstract][Full Text] [Related]
2. Mast cells generate cysteinyl leukotrienes and interferon-beta as well as evince impaired IgE-dependent degranulation upon TLR7 engagement. Witczak P; Pietrzak A; Wódz K; Brzezińska-Błaszczyk E Indian J Exp Biol; 2014 Jun; 52(6):589-96. PubMed ID: 24956889 [TBL] [Abstract][Full Text] [Related]
3. The Response of Tissue Mast Cells to TLR3 Ligand Poly(I:C) Treatment. Witczak P; Brzezińska-Błaszczyk E; Agier J J Immunol Res; 2020; 2020():2140694. PubMed ID: 32185237 [TBL] [Abstract][Full Text] [Related]
4. Increased nasal mucosal interferon and CCL13 response to a TLR7/8 agonist in asthma and allergic rhinitis. Jha A; Thwaites RS; Tunstall T; Kon OM; Shattock RJ; Hansel TT; Openshaw PJM J Allergy Clin Immunol; 2021 Feb; 147(2):694-703.e12. PubMed ID: 32717253 [TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of a functional, alternatively spliced Toll-like receptor 7 (TLR7) and genomic disruption of TLR8 in chickens. Philbin VJ; Iqbal M; Boyd Y; Goodchild MJ; Beal RK; Bumstead N; Young J; Smith AL Immunology; 2005 Apr; 114(4):507-21. PubMed ID: 15804288 [TBL] [Abstract][Full Text] [Related]
6. Sustained IL-4 priming of macrophages enhances the inflammatory response to TLR7/8 ligand R848. Banete A; Gee K; Basta S J Leukoc Biol; 2022 Feb; 111(2):401-413. PubMed ID: 34013552 [TBL] [Abstract][Full Text] [Related]
9. The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma. Grela F; Aumeunier A; Bardel E; Van LP; Bourgeois E; Vanoirbeek J; Leite-de-Moraes M; Schneider E; Dy M; Herbelin A; Thieblemont N J Immunol; 2011 Jan; 186(1):284-90. PubMed ID: 21131420 [TBL] [Abstract][Full Text] [Related]
10. IL-27 Is Essential for Suppression of Experimental Allergic Asthma by the TLR7/8 Agonist R848 (Resiquimod). Jirmo AC; Daluege K; Happle C; Albrecht M; Dittrich AM; Busse M; Habener A; Skuljec J; Hansen G J Immunol; 2016 Dec; 197(11):4219-4227. PubMed ID: 27799314 [TBL] [Abstract][Full Text] [Related]
11. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. Gautier G; Humbert M; Deauvieau F; Scuiller M; Hiscott J; Bates EE; Trinchieri G; Caux C; Garrone P J Exp Med; 2005 May; 201(9):1435-46. PubMed ID: 15851485 [TBL] [Abstract][Full Text] [Related]
12. 17β-Estradiol influences in vitro response of aged rat splenic conventional dendritic cells to TLR4 and TLR7/8 agonists in an agonist specific manner. Stojić-Vukanić Z; Nacka-Aleksić M; Bufan B; Pilipović I; Arsenović-Ranin N; Djikić J; Kosec D; Leposavić G Int Immunopharmacol; 2015 Jan; 24(1):24-35. PubMed ID: 25479725 [TBL] [Abstract][Full Text] [Related]
13. TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. Matsushima H; Yamada N; Matsue H; Shimada S J Immunol; 2004 Jul; 173(1):531-41. PubMed ID: 15210814 [TBL] [Abstract][Full Text] [Related]
14. Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7. Hayashi T; Cottam HB; Chan M; Jin G; Tawatao RI; Crain B; Ronacher L; Messer K; Carson DA; Corr M Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R123-32. PubMed ID: 18480244 [TBL] [Abstract][Full Text] [Related]
15. TLR7 and TLR8 agonist resiquimod (R848) differently regulates MIF expression in cells and organs. Adzavon YM; Zhao P; Lv B; Liu M; Zhang X; Xie F; Yang L; Shang L; Zhang M; Li Q; Ma X Cytokine; 2017 Sep; 97():156-166. PubMed ID: 28648870 [TBL] [Abstract][Full Text] [Related]
16. TLR7 and TLR8 Differentially Activate the IRF and NF-κB Pathways in Specific Cell Types to Promote Inflammation. Bender AT; Tzvetkov E; Pereira A; Wu Y; Kasar S; Przetak MM; Vlach J; Niewold TB; Jensen MA; Okitsu SL Immunohorizons; 2020 Feb; 4(2):93-107. PubMed ID: 32086319 [TBL] [Abstract][Full Text] [Related]
17. TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes. Hofmann H; Vanwalscappel B; Bloch N; Landau NR Retrovirology; 2016 Dec; 13(1):83. PubMed ID: 27905985 [TBL] [Abstract][Full Text] [Related]
18. The ex vivo toll-like receptor 7 tolerance induction in donor lymphocytes prevents murine acute graft-versus-host disease. Zogas N; Karponi G; Iordanidis F; Malasidis S; Paraskevas V; Papadopoulou A; Scouras ZG; Anagnostopoulos A; Yannaki E Cytotherapy; 2018 Jan; 20(1):149-164. PubMed ID: 29150086 [TBL] [Abstract][Full Text] [Related]
19. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. Hart OM; Athie-Morales V; O'Connor GM; Gardiner CM J Immunol; 2005 Aug; 175(3):1636-42. PubMed ID: 16034103 [TBL] [Abstract][Full Text] [Related]